Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 2:15 AM
Ignite Modification Date: 2025-12-26 @ 12:44 AM
NCT ID: NCT01309360
Description: None
Frequency Threshold: 0
Time Frame: None
Study: NCT01309360
Study Brief: Ultrasound-guided Axillary Plexus Block - Dose Reduction of Prilocaine
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Group A : 40ml Prilocaine 1% 40 outpatients : 40ml Prilocaine 1% were administered for axillary plexus block None None 0 40 14 40 View
Group B : 30ml Prilocaine 1% 40 outpatients : 30ml prilocaine 1% were administered for axillary plexus block None None 0 40 5 40 View
Group C : 20ml Prilocaine 1% 40 outpatients : 20ml prilocaine 1% were administered for axillary plexus block None None 0 40 1 40 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders None View
headaches SYSTEMATIC_ASSESSMENT Nervous system disorders None View
objective signs of methemoglobinemia None Blood and lymphatic system disorders None View